Table 5.

Associations between the sum of frequencies of PCP use and urinary concentrations of phthalate metabolites.

Variable	Phthalate metabolite concentration (µg/L)	Crude			Model 1*			Model 2†
		Estimates (β)	SE	p− value	Estimates (β)	SE	p− value	Estimates (β)	SE	p− value
Sum of frequencies of PCP use	MEHHP	2.794	0.032	< 0.001	1.889	0.152	< 0.001	2.287	0.314	< 0.001
	MEOHP	2.462	0.034	< 0.001	1.577	0.159	< 0.001	1.963	0.333	< 0.001
	MECPP	3.274	0.030	< 0.001	2.567	0.139	< 0.001	3.489	0.295	< 0.001
	∑DEHP	4.073	0.029	< 0.001	3.232	0.134	< 0.001	3.920	0.285	< 0.001
	MnBP	3.230	0.042	< 0.001	2.635	0.195	< 0.001	2.712	0.409	< 0.001
	MBzP	0.994	0.039	< 0.001	0.129	0.183	0.480	1.071	0.388	0.006
	MCOP	− 0.037	0.027	0.162	0.207	0.125	0.099	0.557	0.270	0.039
	MCNP	− 0.892	0.024	< 0.001	− 0.735	0.114	< 0.001	− 0.461	0.242	0.057
	MCPP	0.040	0.023	0.076	0.079	0.107	0.462	0.320	0.224	0.153

*Model 1 adjusted for age, sex, and BMI.

^†Model 2 adjusted for Model 1 + smoking status, alcohol consumption status, history of pregnancy, household monthly income, and PCP use within the last 2 days.

SE: standard error, ∑DEHP: sum of MEHHP, MEOHP, and MECPP concentrations.

BMI body mass index, DEHP di-(2-ethylhexyl) phthalate, MBzP monobenzyl phthalate, MCNP monocarboxy-isononly phthalate, MCOP monocarboxyoctyl phthalate, MCPP mono-(3-carboxypropyl) phthalate, MECPP mono-(2-ethyl-5-carboxypentyl) phthalate, MEHHP mono-(2-ethyl-5-hydroxyhexyl) phthalate, MEOHP mono-(2-ethyl-5-oxohexyl) phthalate, MnBP mono-n-butyl phthalate, PCP personal care product.